Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL297453 ((-)-Epigallocatechin Gallate, Epigalocatechin gallate) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
hydroxysteroid 11-beta dehydrogenase 1/11-beta-hydroxysteroid dehydrogenase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4235] [GtoPdb: 2763] [UniProtKB: P28845] | ||||||||
ChEMBL | Inhibition of human 11beta-HSD1 incubated for 2 hrs by HPLC analysis | B | 4.24 | pIC50 | 57990 | nM | IC50 | Eur J Med Chem (2020) 191: 112134-112134 [PMID:32088493] |
hydroxysteroid 11-beta dehydrogenase 2/11-beta-hydroxysteroid dehydrogenase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3746] [GtoPdb: 3143] [UniProtKB: P80365] | ||||||||
ChEMBL | Inhibition of human 11beta-HSD2 incubated for 2 hrs by HPLC analysis | B | 4.68 | pIC50 | 20930 | nM | IC50 | Eur J Med Chem (2020) 191: 112134-112134 [PMID:32088493] |
3-oxoacyl-acyl-carrier protein reductase in Plasmodium falciparum (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4513] [UniProtKB: Q965D6] | ||||||||
ChEMBL | Inhibition of FabG | B | 6.52 | pIC50 | 300 | nM | IC50 | J Med Chem (2006) 49: 3345-3353 [PMID:16722653] |
3-oxoacyl-(Acyl-carrier protein) reductase in Plasmodium falciparum 3D7 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2424511] [UniProtKB: Q8I2S7] | ||||||||
ChEMBL | Inhibition of recombinant Plasmodium falciparum 3D7 FabG using acetoacetyl-CoA as substrate after 10 mins in presence of NADPH | B | 6.49 | pIC50 | 320 | nM | IC50 | J Med Chem (2013) 56: 7516-7526 [PMID:24063369] |
40S ribosomal protein SA in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6119] [UniProtKB: P08865] | ||||||||
ChEMBL | Binding affinity to His-tagged Laminin receptor in human A549 cells assessed as dissociation constant by surface plasmon resonance assay | B | 7.4 | pKd | 39.9 | nM | Kd | Bioorg Med Chem (2023) 96: 117483-117483 [PMID:37951136] |
6-phosphogluconate dehydrogenase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3404] [UniProtKB: P52209] | ||||||||
ChEMBL | Inhibition of 6PGD | B | 6.14 | pIC50 | 720 | nM | IC50 | Bioorg Med Chem (2008) 16: 3580-3586 [PMID:18313308] |
ADAMTS4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2318] [GtoPdb: 1677] [UniProtKB: O75173] | ||||||||
ChEMBL | Inhibition of ADAMTS-4 (unknown origin) | B | 7 | pIC50 | 100 | nM | IC50 | J Med Chem (2022) 65: 13505-13532 [PMID:36250680] |
ADAMTS5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2285] [GtoPdb: 1678] [UniProtKB: Q9UNA0] | ||||||||
ChEMBL | Inhibition of ADAMTS-5 (unknown origin) | B | 7 | pIC50 | 100 | nM | IC50 | J Med Chem (2022) 65: 13505-13532 [PMID:36250680] |
Amyloid-beta A4 protein in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2487] [UniProtKB: P05067] | ||||||||
ChEMBL | Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay | B | 4 | pIC50 | 100000 | nM | IC50 | J Med Chem (2013) 56: 4135-4155 [PMID:23484434] |
ChEMBL | Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method | B | 5.34 | pIC50 | 4600 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 3108-3112 [PMID:24878198] |
ChEMBL | Inhibition of amyloid beta1-40 (unknown origin) aggregation | B | 5.52 | pIC50 | 3000 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 3108-3112 [PMID:24878198] |
ChEMBL | Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay | B | 6.3 | pIC50 | 500 | nM | IC50 | J Nat Prod (2015) 78: 1221-1230 [PMID:25978520] |
ChEMBL | Inhibition of amyloid beta (unknown origin) aggregation | B | 6.74 | pIC50 | 180 | nM | IC50 | Eur J Med Chem (2018) 152: 570-589 [PMID:29763806] |
ChEMBL | Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation incubated for 24 hrs by ThioflavinT-dye based fluorescence analysis | B | 6.85 | pIC50 | 140 | nM | IC50 | J Nat Prod (2023) 86: 882-890 [PMID:36861650] |
Anthrax lethal factor in Bacillus anthracis (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4372] [UniProtKB: P15917] | ||||||||
ChEMBL | Inhibition of Bacillus anthracis lethal factor | B | 7.01 | pIC50 | 97 | nM | IC50 | Eur J Med Chem (2021) 226: 113877-113877 [PMID:34624823] |
BCL2 apoptosis regulator/Apoptosis regulator Bcl-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4860] [GtoPdb: 2844] [UniProtKB: P10415] | ||||||||
ChEMBL | Displacement of NLWAAQRYGRELRRMSD-K(FITC)-FVD from Bcl-2 (unknown origin) by fluorescence polarization assay | B | 6.47 | pKi | 335 | nM | Ki | Med Chem Res (2010) 19: 817-835 |
ChEMBL | Binding affinity to BCL2 | B | 6.63 | pKi | 234.42 | nM | Ki | Proc Natl Acad Sci U S A (2007) 104: 19512-19517 [PMID:18040043] |
beta-secretase 1/Beta-secretase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4822] [GtoPdb: 2330] [UniProtKB: P56817] | ||||||||
ChEMBL | Inhibition of BACE1 using Rh-EVNLDAEFK-Quencher as substrate | B | 5.8 | pIC50 | 1600 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 1408-1414 [PMID:22225636] |
ChEMBL | Inhibition of human BACE-1 | B | 5.8 | pIC50 | 1600 | nM | IC50 | Eur J Med Chem (2018) 152: 570-589 [PMID:29763806] |
ChEMBL | Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate by HTRF assay | B | 6.12 | pIC50 | 757 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 1408-1414 [PMID:22225636] |
CB1 receptor/Cannabinoid CB1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL218] [GtoPdb: 56] [UniProtKB: P21554] | ||||||||
ChEMBL | Displacement of [3H]-CP5594 from human recombinant CB1 receptor expressed in Chem1 cells after 90 mins by scintillation counting method | B | 4.47 | pKi | 33600 | nM | Ki | J Med Chem (2017) 60: 9413-9436 [PMID:28654265] |
ChEMBL | Displacement of [3H]-CP55940 from CB1 receptor (unknown origin) | B | 4.47 | pKi | 33600 | nM | Ki | J Nat Prod (2019) 82: 636-646 [PMID:30816712] |
CB2 receptor/Cannabinoid CB2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL253] [GtoPdb: 57] [UniProtKB: P34972] | ||||||||
ChEMBL | Displacement of [3H]-CP55940 from CB2 receptor (unknown origin) | B | 4.37 | pKi | 42800 | nM | Ki | J Nat Prod (2019) 82: 636-646 [PMID:30816712] |
casein kinase 1 epsilon/Casein kinase I epsilon in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4937] [GtoPdb: 1998] [UniProtKB: P49674] | ||||||||
ChEMBL | Inhibition of recombinant human CK1epsilon expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 6.44 | pIC50 | 365 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
CpG DNA methylase in Spiroplasma monobiae (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4373] [UniProtKB: P15840] | ||||||||
ChEMBL | Competitive inhibition of Spiroplasma sp. MQ1 SssI methyltransferase using pUC18 as substrate measured for 10 mins by Dixon plot analysis | B | 7.55 | pKi | 28 | nM | Ki | Eur J Med Chem (2012) 55: 243-254 [PMID:22854677] |
CREB binding protein/CREB-binding protein in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5747] [GtoPdb: 2734] [UniProtKB: Q92793] | ||||||||
ChEMBL | Inhibition of recombinant GST-tagged CBP (unknown origin) using histone H4 peptide substrate assessed as reduction in NADH formation by spectrophotometric analysis | B | 4.3 | pIC50 | 50000 | nM | IC50 | J Med Chem (2016) 59: 1249-1270 [PMID:26701186] |
ChEMBL | Inhibition of CBP (unknown origin) | B | 4.3 | pIC50 | 50000 | nM | IC50 | Eur J Med Chem (2019) 178: 259-286 [PMID:31195169] |
cyclin dependent kinase 5/Cyclin-dependent kinase 5/CDK5 activator 1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL1907600] [GtoPdb: 1977] [UniProtKB: Q00535, Q15078] | ||||||||
ChEMBL | Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 6.37 | pIC50 | 431 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
Dihydrofolate reductase in Mycobacterium tuberculosis (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6065] [UniProtKB: P9WNX1] | ||||||||
ChEMBL | Inhibition of Mycobacterium tuberculosis DHFR | B | 4.96 | pIC50 | 10910 | nM | IC50 | Eur J Med Chem (2020) 195: 112268-112268 [PMID:32298876] |
dipeptidyl peptidase 4/Dipeptidyl peptidase IV in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL284] [GtoPdb: 1612] [UniProtKB: P27487] | ||||||||
ChEMBL | Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay | B | 4.99 | pIC50 | 10210 | nM | IC50 | Eur J Med Chem (2018) 151: 145-157 [PMID:29609120] |
DNA methyltransferase 1/DNA (cytosine-5)-methyltransferase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1993] [GtoPdb: 2605] [UniProtKB: P26358] | ||||||||
ChEMBL | Inhibition of His6-tagged human recombinant DNMT1 expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid scintillation counting method | B | 6.3 | pIC50 | 500 | nM | IC50 | J Med Chem (2015) 58: 2569-2583 [PMID:25406944] |
DNA repair protein RAD52 homolog in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2362978] [UniProtKB: P43351] | ||||||||
ChEMBL | Inhibition of RAD52 (unknown origin) assessed as effect on RAD52-mediated annealing of complementary oligonucleotides using T-28 ssDNA substrate by FRET assay | B | 5.17 | pIC50 | 6700 | nM | IC50 | US-20180209956-A1. HTS Assay for Identifying Small Molecule Inhibitors of RAD52 and Uses of Identified Small Molecule Inhibitors for Treatment and Prevention of BRCA-Deficient Malignancies (2018) |
ChEMBL | Inhibition of RAD52 (unknown origin) assessed as effect on RAD52-mediated annealing of complementary oligonucleotides using T-28 ssDNA substrate in presence of replication protein A by FRET assay | B | 5.43 | pIC50 | 3700 | nM | IC50 | US-20180209956-A1. HTS Assay for Identifying Small Molecule Inhibitors of RAD52 and Uses of Identified Small Molecule Inhibitors for Treatment and Prevention of BRCA-Deficient Malignancies (2018) |
ChEMBL | Inhibition of RAD52 (unknown origin) assessed as reduction in RAD52-ssDNA interaction using Cy3-dT30-Cy5 ssDNA in presence of replication protein A by FRET assay | B | 5.8 | pIC50 | 1600 | nM | IC50 | US-20180209956-A1. HTS Assay for Identifying Small Molecule Inhibitors of RAD52 and Uses of Identified Small Molecule Inhibitors for Treatment and Prevention of BRCA-Deficient Malignancies (2018) |
ChEMBL | Inhibition of RAD52 (unknown origin) assessed as reduction in RAD52-ssDNA interaction using Cy3-dT30-Cy5 ssDNA by FRET assay | B | 6.56 | pIC50 | 277 | nM | IC50 | US-20180209956-A1. HTS Assay for Identifying Small Molecule Inhibitors of RAD52 and Uses of Identified Small Molecule Inhibitors for Treatment and Prevention of BRCA-Deficient Malignancies (2018) |
ChEMBL | Inhibition of 6His-tagged human RD52 assessed as reduction in RD52 binding to Cy3-dT30-Cy5 ssDNA incubated for 30 mins by FRET assay | B | 6.56 | pIC50 | 277 | nM | IC50 | J Med Chem (2020) 63: 14151-14183 [PMID:33135887] |
CDC like kinase 1/Dual specificity protein kinase CLK1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4224] [GtoPdb: 1990] [UniProtKB: P49759] | ||||||||
ChEMBL | Inhibition of recombinant human CLK1 expressed in Sf9 insect cells using myelin basic protein as substrate incubated for 110 mins in presence of ATP by non-radioactive ADP-Glo luminescence microplate reader assay | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
ChEMBL | Inhibition of recombinant human CLK1 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 7.15 | pIC50 | 71.6 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
CDC like kinase 2/Dual specificity protein kinase CLK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4225] [GtoPdb: 1991] [UniProtKB: P49760] | ||||||||
ChEMBL | Inhibition of recombinant human CLK2 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5.88 | pIC50 | 1317 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
CDC like kinase 3/Dual specificity protein kinase CLK3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4226] [GtoPdb: 1992] [UniProtKB: P49761] | ||||||||
ChEMBL | Inhibition of recombinant human CLK3 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5.59 | pIC50 | 2577 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
CDC like kinase 4/Dual specificity protein kinase CLK4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4203] [GtoPdb: 1993] [UniProtKB: Q9HAZ1] | ||||||||
ChEMBL | Inhibition of recombinant human CLK4 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 6.43 | pIC50 | 367.7 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
dual specificity tyrosine phosphorylation regulated kinase 1A in Human [GtoPdb: 2009] [UniProtKB: Q13627] | ||||||||
GtoPdb | - | - | 6.48 | pIC50 | 330 | nM | IC50 | Brain Sci (2018) 8: [PMID:30332747] |
dual specificity tyrosine phosphorylation regulated kinase 1A/Dual specificity tyrosine-phosphorylation-regulated kinase 1A in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5508] [GtoPdb: 2009] [UniProtKB: Q63470] | ||||||||
ChEMBL | Inhibition of rat Dyrk1A using Woodtide as substrate after 40 mins by P81 membrane assay in presence of [33P]-g-ATP | B | 6.48 | pIC50 | 330 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 2948-2952 [PMID:26048785] |
dual specificity tyrosine phosphorylation regulated kinase 1A/Dual-specificity tyrosine-phosphorylation regulated kinase 1A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2292] [GtoPdb: 2009] [UniProtKB: Q13627] | ||||||||
ChEMBL | Inhibition of GST-tagged human DYRK1A using dephosphorylated MBP as substrate after 10 mins by Kinase-Glo plus luminescent kinase assay | B | 4.87 | pIC50 | 13440 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 168-171 [PMID:22154664] |
ChEMBL | Inhibition of recombinant human DYRK1A expressed in Escherichia coli using DYRKtide peptide as substrate incubated for 110 mins in presence of ATP by non-radioactive ADP-Glo luminescence microplate reader assay | B | 6.12 | pIC50 | 765.6 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
ChEMBL | Inhibition of recombinant human DYRK1A expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 6.31 | pIC50 | 490.7 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
GtoPdb | - | - | 6.48 | pIC50 | 330 | nM | IC50 | Brain Sci (2018) 8: [PMID:30332747] |
ChEMBL | Inhibition of DYRK1A (unknown origin) | B | 6.48 | pIC50 | 330 | nM | IC50 | Bioorg Med Chem (2022) 70: 116921-116921 [PMID:35863237] |
ChEMBL | Inhibition of DYRK1A (unknown origin) | B | 6.48 | pIC50 | 330 | nM | IC50 | Eur J Med Chem (2018) 158: 559-592 [PMID:30243157] |
ChEMBL | Inhibition of human GST-fused DYRK1A expressed in Escherichia coli using KISGRLSPIMTEQ as substrate | B | 6.48 | pIC50 | 330 | nM | IC50 | J Med Chem (2013) 56: 9569-9585 [PMID:24188002] |
ChEMBL | Inhibition of human recombinant GST-tagged DYRK1A expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 40 mins in presence of [gamma33P-ATP] | B | 6.48 | pIC50 | 330 | nM | IC50 | J Med Chem (2018) 61: 9791-9810 [PMID:29985601] |
ChEMBL | Inhibition of DYRK1A (unknown origin) using HT-497 as substrate preincubated with compound followed by substrate addition and measured after 30 mins in the presence of ATP by ELISA analysis | B | 6.63 | pIC50 | 232 | nM | IC50 | Bioorg Med Chem Lett (2022) 64: 128675-128675 [PMID:35292341] |
dual specificity tyrosine phosphorylation regulated kinase 1B/Dual specificity tyrosine-phosphorylation-regulated kinase 1B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5543] [GtoPdb: 2010] [UniProtKB: Q9Y463] | ||||||||
ChEMBL | Inhibition of recombinant human DYRK1B expressed in Sf9 insect cells using DYRKtide peptide as substrate incubated for 110 mins in presence of ATP by non-radioactive ADP-Glo luminescence microplate reader assay | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
ChEMBL | Inhibition of recombinant human DYRK1B expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 6.15 | pIC50 | 713.6 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
dual specificity tyrosine phosphorylation regulated kinase 2/Dual-specificity tyrosine-phosphorylation regulated kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4376] [GtoPdb: 2011] [UniProtKB: Q92630] | ||||||||
ChEMBL | Inhibition of recombinant human DYRK2 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5.7 | pIC50 | 2004 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
dual specificity tyrosine phosphorylation regulated kinase 3/Dual-specificity tyrosine-phosphorylation regulated kinase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4575] [GtoPdb: 2012] [UniProtKB: O43781] | ||||||||
ChEMBL | Inhibition of recombinant human DYRK3 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5.79 | pIC50 | 1625 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
dual specificity tyrosine phosphorylation regulated kinase 4/Dual specificity tyrosine-phosphorylation-regulated kinase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075115] [GtoPdb: 2013] [UniProtKB: Q9NR20] | ||||||||
ChEMBL | Inhibition of recombinant human DYRK4 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5.28 | pIC50 | 5200 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
Enoyl-[acyl-carrier-protein] reductase in Escherichia coli (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1857] [UniProtKB: P0AEK4] | ||||||||
ChEMBL | Inhibition of Escherichia coli ENR | B | 4.82 | pIC50 | 15000 | nM | IC50 | J Med Chem (2007) 50: 765-775 [PMID:17263522] |
ChEMBL | Inhibition of Escherichia coli FabI using trans-2-octanoyl-N-acetylcysteamine as substrate by spectrophotometry | B | 5.3 | pIC50 | 5000 | nM | IC50 | Bioorg Med Chem Lett (2020) 30: 127651-127651 [PMID:33130290] |
Enoyl-acyl-carrier protein reductase in Plasmodium falciparum (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4150] [UniProtKB: Q965D5] | ||||||||
ChEMBL | Inhibition of Plasmodium falciparum ENR using NADH substrate | B | 6.73 | pKi | 186 | nM | Ki | J Med Chem (2007) 50: 765-775 [PMID:17263522] |
ChEMBL | Inhibition of Plasmodium falciparum ENR using crotonyl-CoA substrate | B | 7.1 | pKi | 79 | nM | Ki | J Med Chem (2007) 50: 765-775 [PMID:17263522] |
ChEMBL | Inhibition of Plasmodium falciparum ENR in presence of triclosan | B | 8.1 | pKi | 8 | nM | Ki | J Med Chem (2007) 50: 765-775 [PMID:17263522] |
ChEMBL | Inhibition of Plasmodium falciparum ENR | B | 6.6 | pIC50 | 250 | nM | IC50 | J Med Chem (2007) 50: 765-775 [PMID:17263522] |
ChEMBL | Inhibition of FabI | B | 6.7 | pIC50 | 200 | nM | IC50 | J Med Chem (2006) 49: 3345-3353 [PMID:16722653] |
Fatty acid synthase in Plasmodium falciparum (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4512] [UniProtKB: Q965D7] | ||||||||
ChEMBL | Inhibition of FabZ | B | 6.4 | pIC50 | 400 | nM | IC50 | J Med Chem (2006) 49: 3345-3353 [PMID:16722653] |
ChEMBL | Inhibition of recombinant Plasmodium falciparum FabZ using crotonoyl-CoA as substrate after 10 mins | B | 7.52 | pIC50 | 30 | nM | IC50 | J Med Chem (2013) 56: 7516-7526 [PMID:24063369] |
Fatty acid synthase in Chicken (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1795136] [UniProtKB: P12276] | ||||||||
ChEMBL | Inhibition of chicken liver FASN ketoreductase activity | B | 4 | pIC50 | 100000 | nM | IC50 | J Med Chem (2011) 54: 5615-5638 [PMID:21726077] |
ChEMBL | Inhibition of chicken liver FASN | B | 4.28 | pIC50 | 52000 | nM | IC50 | J Med Chem (2011) 54: 5615-5638 [PMID:21726077] |
ChEMBL | Inhibition of chicken liver FASN using acetyl-CoA, malonyl-CoA and NADPH as substrate by spectrophotometer analysis | B | 4.28 | pIC50 | 52000 | nM | IC50 | Eur J Med Chem (2019) 182: 111597-111597 [PMID:31422225] |
fatty acid synthase/Fatty acid synthase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4158] [GtoPdb: 2608] [UniProtKB: P49327] | ||||||||
ChEMBL | Inhibition of FAS | B | 4.28 | pIC50 | 51970 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 6045-6047 [PMID:20817450] |
Genome polyprotein in Zika virus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523954] [UniProtKB: A0A024AXB9] | ||||||||
ChEMBL | Inhibition of Zika virus NS2B (1421 to 1469 residues) - NS3 (1503 to 1688 residues) expressed in Escherichia coli BL21(DE3) cells using Dabcyl-KTSAVLQSGFRKME-Edans as substrate after 11 mins by FRET assay | B | 4.06 | pIC50 | 87000 | nM | IC50 | J Med Chem (2020) 63: 470-489 [PMID:31549836] |
Glucose-6-phosphate 1-dehydrogenase in Saccharomyces cerevisiae S288c (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075249] [UniProtKB: P11412] | ||||||||
ChEMBL | Inhibition of yeast G6PD | B | 6.6 | pIC50 | 250 | nM | IC50 | Bioorg Med Chem (2008) 16: 3580-3586 [PMID:18313308] |
glycogen synthase kinase 3 beta/Glycogen synthase kinase-3 beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL262] [GtoPdb: 2030] [UniProtKB: P49841] | ||||||||
ChEMBL | Inhibition of recombinant human GSK-3beta expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5.2 | pIC50 | 6269 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
GroEL/GroES in Escherichia coli (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL4106139] [UniProtKB: Q548M1, Q7BGE6] | ||||||||
ChEMBL | Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity after 45 mins by Fe(SCN)3 dye based spectrometric analysis | B | 6.24 | pIC50 | 580 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 1106-1112 [PMID:30852084] |
ChEMBL | Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme activity using sodium mesoxalate as substrate after 20 to 40 mins by malachite green dye based spectrometric analysis | B | 6.44 | pIC50 | 360 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 1106-1112 [PMID:30852084] |
MET proto-oncogene, receptor tyrosine kinase/Hepatocyte growth factor receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3717] [GtoPdb: 1815] [UniProtKB: P08581] | ||||||||
ChEMBL | Inhibition of MET kinase by Dixon plot analysis | B | 5.48 | pKi | 3300 | nM | Ki | J Med Chem (2009) 52: 6543-6545 [PMID:19839593] |
ChEMBL | Inhibition of MET kinase | B | 5 | pIC50 | 10000 | nM | IC50 | J Med Chem (2009) 52: 6543-6545 [PMID:19839593] |
lysine acetyltransferase 5/Histone acetyltransferase KAT5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5750] [GtoPdb: 2664] [UniProtKB: Q92993] | ||||||||
ChEMBL | Inhibition of recombinant TIP60 (unknown origin) using histone H4 peptide substrate assessed as reduction in NADH formation by spectrophotometric analysis | B | 4.15 | pIC50 | 70000 | nM | IC50 | J Med Chem (2016) 59: 1249-1270 [PMID:26701186] |
ChEMBL | Inhibition of Tip60 (unknown origin) | B | 4.15 | pIC50 | 70000 | nM | IC50 | Eur J Med Chem (2019) 178: 259-286 [PMID:31195169] |
E1A binding protein p300/Histone acetyltransferase p300 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3784] [GtoPdb: 2735] [UniProtKB: Q09472] | ||||||||
GtoPdb | - | - | 4.52 | pIC50 | 30000 | nM | IC50 | Cancer Res (2009) 69: 583-92 [PMID:19147572] |
ChEMBL | Inhibition of recombinant GST-tagged p300 (unknown origin) using histone H4 peptide substrate assessed as reduction in NADH formation by spectrophotometric analysis | B | 4.52 | pIC50 | 30000 | nM | IC50 | J Med Chem (2016) 59: 1249-1270 [PMID:26701186] |
ChEMBL | Inhibition of P300 (unknown origin) | B | 4.52 | pIC50 | 30000 | nM | IC50 | Eur J Med Chem (2019) 178: 259-286 [PMID:31195169] |
lysine acetyltransferase 2B/Histone acetyltransferase PCAF in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5500] [GtoPdb: 2737] [UniProtKB: Q92831] | ||||||||
GtoPdb | - | - | 4.22 | pIC50 | 60000 | nM | IC50 | Cancer Res (2009) 69: 583-92 [PMID:19147572] |
ChEMBL | Inhibition of recombinant PCAF (unknown origin) using histone H4 peptide substrate assessed as reduction in NADH formation by spectrophotometric analysis | B | 4.22 | pIC50 | 60000 | nM | IC50 | J Med Chem (2016) 59: 1249-1270 [PMID:26701186] |
ChEMBL | Inhibition of PCAF (unknown origin) | B | 4.22 | pIC50 | 60000 | nM | IC50 | Eur J Med Chem (2019) 178: 259-286 [PMID:31195169] |
HSP60/HSP10 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL4106131] [UniProtKB: P10809, P61604] | ||||||||
ChEMBL | Inhibition of human N-terminal octa-His-tagged HSP60 expressed in Escherichia coli Rosetta(DE3) pLysS/human HSP10 expressed in Escherichia coli Rosetta(DE3) assessed as reduction in HSP60/HSP10-mediated denatured MDH refolding by measuring MDH enzyme activity using sodium mesoxalate as substrate after 40 to 60 mins by malachite green dye based spectrometric analysis | B | 5.64 | pIC50 | 2300 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 1106-1112 [PMID:30852084] |
Human immunodeficiency virus type 1 reverse transcriptase in Human immunodeficiency virus 1 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL247] [UniProtKB: Q72547] | ||||||||
ChEMBL | Inhibition of polymerization in wild type HIV-1 RT with poly rC/dG12-18 template primer and [3H]dGTP | B | 6.14 | pIC50 | 730 | nM | IC50 | Bioorg Med Chem Lett (2001) 11: 2763-2767 [PMID:11591519] |
Latent membrane protein 1 in Human herpesvirus 4 (strain B95-8) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1795089] [UniProtKB: P03230] | ||||||||
ChEMBL | Binding affinity to Epstein Barr virus LMP1 assessed as dissociation constant | B | 6.44 | pKd | 360 | nM | Kd | Bioorg Med Chem (2023) 96: 117483-117483 [PMID:37951136] |
elastase, neutrophil expressed/Leukocyte elastase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL248] [GtoPdb: 2358] [UniProtKB: P08246] | ||||||||
ChEMBL | Inhibition of human neutrophil elastase | B | 4.89 | pIC50 | 12800 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 513-515 [PMID:20004577] |
MAPK activated protein kinase 5/MAP kinase-activated protein kinase 5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3094] [GtoPdb: 2096] [UniProtKB: Q8IW41] | ||||||||
ChEMBL | Inhibition of PRAK (unknown origin) | B | 6 | pIC50 | 1000 | nM | IC50 | J Med Chem (2018) 61: 9791-9810 [PMID:29985601] |
mitogen-activated protein kinase 14/MAP kinase p38 alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL260] [GtoPdb: 1499] [UniProtKB: Q16539] | ||||||||
ChEMBL | Inhibition of p38alpha after 1 hr by ELISA | B | 5.66 | pIC50 | 2210 | nM | IC50 | J Nat Prod (2010) 73: 2035-2041 [PMID:21080642] |
MMP14/Matrix metalloproteinase 14 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3869] [GtoPdb: 1638] [UniProtKB: P50281] | ||||||||
ChEMBL | Inhibition of human recombinant MT1-MMP expressed in Escherichia coli by fluorogenic peptide cleavage assay | B | 5.17 | pIC50 | 6800 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 4171-4174 [PMID:19524436] |
MMP2/Matrix metalloproteinase-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL333] [GtoPdb: 1629] [UniProtKB: P08253] | ||||||||
ChEMBL | Inhibition of human recombinant MMP2 expressed in Escherichia coli by fluorogenic peptide cleavage assay | B | 5.02 | pIC50 | 9600 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 4171-4174 [PMID:19524436] |
MMP7/Matrix metalloproteinase 7 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4073] [GtoPdb: 1631] [UniProtKB: P09237] | ||||||||
ChEMBL | Inhibition of human recombinant MMP7 expressed in Escherichia coli by fluorogenic peptide cleavage assay | B | 4.67 | pIC50 | 21500 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 4171-4174 [PMID:19524436] |
Microtubule-associated protein tau in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293224] [UniProtKB: P10636] | ||||||||
ChEMBL | Inhibition of human recombinant brain tau protein (412 amino acid residues) filament assembly expressed in Escherichia coli BL21(DE3) by electron microscopic analysis in presence of heparin | B | 5.74 | pIC50 | 1800 | nM | IC50 | J Med Chem (2013) 56: 4135-4155 [PMID:23484434] |
NAD kinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6177] [UniProtKB: O95544] | ||||||||
ChEMBL | Binding affinity to N-terminal full length NADK (unknown origin) expressed in Escherichia coli BL21(DE3) cells assessed as dissociation constant by surface plasmon resonance assay | B | 5.75 | pKd | 1780 | nM | Kd | ACS Med Chem Lett (2022) 13: 1699-1706 [PMID:36385933] |
ChEMBL | Non-competitive inhibition of N-terminal full length NADK (unknown origin) expressed in Escherichia coli BL21(DE3) cells by HDX-MS analysis | B | 5.48 | pKi | 3280 | nM | Ki | ACS Med Chem Lett (2022) 13: 1699-1706 [PMID:36385933] |
ChEMBL | Inhibition of NADK delta 95 kinase domain (unknown origin) at 80 uM measured after 30 mins by HDX-MS analysis | B | 6.02 | pIC50 | 960 | nM | IC50 | ACS Med Chem Lett (2022) 13: 1699-1706 [PMID:36385933] |
peptidylprolyl cis/trans isomerase, NIMA-interacting 1/Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2288] [GtoPdb: 3171] [UniProtKB: Q13526] | ||||||||
ChEMBL | Inhibition of full length Pin1 (unknown origin) using WFY(pS)PR-pNA as substrate by spectrophotometric analysis | B | 4.7 | pIC50 | 20000 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 4283-4291 [PMID:23796453] |
ABCB1/P-glycoprotein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4302] [GtoPdb: 768] [UniProtKB: P08183] | ||||||||
ChEMBL | Modulation of P-gp (unknown origin) transfected in human MDA435/LCC6MDR cells assessed as reversible of paclitaxel resistance measured as IC50 for paclitaxel at 1 uM after 5 days by CellTiter 96 Aqueous assay | B | 6.91 | pIC50 | 124.1 | nM | IC50 | J Med Chem (2015) 58: 4529-4549 [PMID:25985195] |
ChEMBL | Modulation of P-gp (unknown origin) transfected in human MDA435/LCC6MDR cells assessed as reversible of paclitaxel resistance measured as IC50 for paclitaxel at 10 uM after 5 days by CellTiter 96 Aqueous assay | B | 6.91 | pIC50 | 122.6 | nM | IC50 | J Med Chem (2015) 58: 4529-4549 [PMID:25985195] |
Phosphoglycerate mutase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3334418] [UniProtKB: P18669] | ||||||||
ChEMBL | Inhibition of recombinant human His-tagged PGAM1 expressed in Escherichia coli BL21 competent cells by kinase-glo assay | B | 6.31 | pIC50 | 490 | nM | IC50 | Bioorg Med Chem (2018) 26: 1961-1970 [PMID:29530347] |
ChEMBL | Inhibition of recombinant His-tagged PGAM1 (unknown origin) expressed in Escherichia coli BL21 using 3-PG as substrate in presence of ADP by Kinase-Glo max luminescent assay | B | 6.31 | pIC50 | 490 | nM | IC50 | Bioorg Med Chem Lett (2021) 36: 127820-127820 [PMID:33513389] |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/PI3-kinase p110-alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4005] [GtoPdb: 2153] [UniProtKB: P42336] | ||||||||
ChEMBL | Inhibition of PIK3alpha (unknown origin) expressed in baculovirus assessed as inhibition constant using PIP2 as substrate in presence of [gamma-32P]ATP incubated for 30 mins by scintillation proximity assay | B | 6.42 | pKi | 380 | nM | Ki | Eur J Med Chem (2020) 208: 112820-112820 [PMID:32966896] |
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
ChEMBL | Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54 | F | 4.59 | pIC50 | 25500 | nM | IC50 | J Med Chem (2006) 49: 3345-3353 [PMID:16722653] |
ChEMBL | Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 | F | 5 | pIC50 | 9900 | nM | IC50 | J Med Chem (2006) 49: 3345-3353 [PMID:16722653] |
ChEMBL | Antimalarial activity against chloroquine-resistant/mefloquine-sensitive Plasmodium falciparum W2 by malaria SYBR green 1-based fluorescence (MSF) assay | F | 5.85 | pIC50 | 1400 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 327-332 [PMID:25488841] |
ChEMBL | Antimalarial activity against chloroquine /mefloquine/pyrimethamine-resistant Plasmodium falciparum C235 by malaria SYBR green 1-based fluorescence (MSF) assay | F | 6.21 | pIC50 | 610 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 327-332 [PMID:25488841] |
ChEMBL | Antimalarial activity against chloroquine-sensitive/mefloquine-resistant Plasmodium falciparum D6 by malaria SYBR green 1-based fluorescence (MSF) assay | F | 7.14 | pIC50 | 73 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 327-332 [PMID:25488841] |
embryonic ectoderm development/Polycomb protein EED in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2189117] [GtoPdb: 2487] [UniProtKB: O75530] | ||||||||
ChEMBL | Binding affinity to EED (unknown origin) assessed as dissociation constant SPR assay | B | 4.82 | pKd | 15100 | nM | Kd | Eur J Med Chem (2022) 231: 114144-114144 [PMID:35093670] |
Polymerase acidic protein in Influenza A virus (A/Puerto Rico/8/1934(H1N1)) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1169598] [UniProtKB: P03433] | ||||||||
ChEMBL | Inhibition of Influenza A virus N-terminal domain of PA endonuclease using 6FAM-TGGCAATATCAGCTCCACA-MGBNFQ as fluorescent substrate by FRET analysis | B | 5.19 | pIC50 | 6450 | nM | IC50 | J Med Chem (2023) 66: 188-219 [PMID:36521178] |
ChEMBL | Inhibition of Influenza A virus N-terminal domain of PA endonuclease using 6FAM-TGGCAATATCAGCTCCACA-MGBNFQ as fluorescent substrate by FRET analysis | B | 5.23 | pIC50 | 5860 | nM | IC50 | Eur J Med Chem (2022) 227: 113929-113929 [PMID:34700269] |
mPGES1/Prostaglandin E synthase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5658] [GtoPdb: 1377] [UniProtKB: O14684] | ||||||||
ChEMBL | Inhibition of mPGES1 in human A549 cell microsomal membrane using pGH2 as substrate pretreated for 15 mins followed by substrate addition and measured after 1 min by RP-HPLC method | B | 5.74 | pIC50 | 1800 | nM | IC50 | Eur J Med Chem (2018) 153: 2-28 [PMID:29329790] |
proteasome 20S subunit beta 5/Proteasome Macropain subunit MB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4662] [GtoPdb: 2406] [UniProtKB: P28074] | ||||||||
ChEMBL | Inhibition of chymotrypsin-like activity of human 26S proteasome in human Jurkat cells assessed as decrease in AMC hydrolysis using Z-Gly-Gly-Arg-AMC as substrate preincubated for 12 hrs followed by addition of substrate and measured after 2 hrs by fluorometric analysis | B | 4.74 | pIC50 | 18000 | nM | IC50 | Eur J Med Chem (2019) 167: 291-311 [PMID:30776692] |
ChEMBL | Inhibition of chymotrypsin-like activity of human 26S proteasome extracted from human Jurkat cells assessed as decrease in AMC hydrolysis using Z-Gly-Gly-Arg-AMC as substrate after 90 mins by fluorometric analysis | B | 6 | pIC50 | 1000 | nM | IC50 | Eur J Med Chem (2019) 167: 291-311 [PMID:30776692] |
ChEMBL | Inhibition of chymotrypsin-like activity of purified human 20S proteasome assessed as decrease in AMC hydrolysis using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 30 mins by fluorometric analysis | B | 7.07 | pIC50 | 86 | nM | IC50 | Eur J Med Chem (2019) 167: 291-311 [PMID:30776692] |
Replicase polyprotein 1ab in Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (Betacoronavirus England 1) (Humancoronavirus EMC) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4295557] [UniProtKB: K9N7C7] | ||||||||
ChEMBL | MERS_3CL Pro protease inhibition IC50 by FRET kind of response from peptide substrate | F | 5 | pIC50 | >10000 | nM | IC50 | Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen |
ChEMBL | MERS_3CL Pro protease inhibition IC50 by FRET kind of response from peptide substrate | F | 5 | pIC50 | >10000 | nM | IC50 | Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen |
CoV Replicase polyprotein 1ab/CoV RNA-dependent RNA polymerase/CoV Non-structural protein 15/CoV Non-structural protein 13/Replicase polyprotein 1ab in Severe acute respiratory syndrome coronavirus 2 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523582] [GtoPdb: 3125, 3139, 3206, 3261] [UniProtKB: P0DTD1] | ||||||||
ChEMBL | SARS-CoV-2 3CL-Pro protease inhibition IC50 determined by FRET kind of response from peptide substrate | F | 5.8 | pIC50 | 1580 | nM | IC50 | Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen |
ChEMBL | SARS-CoV-2 3CL-Pro protease inhibition IC50 determined by FRET kind of response from peptide substrate | F | 6.14 | pIC50 | 720 | nM | IC50 | Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen |
Sarcoplasmic/endoplasmic reticulum calcium ATP-ase in Rabbit (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4693] [UniProtKB: P04191] | ||||||||
ChEMBL | Inhibition of rabbit skeletal muscle microsomes SERCA1a | B | 4.92 | pIC50 | 12000 | nM | IC50 | J Med Chem (2020) 63: 1937-1963 [PMID:32030976] |
mechanistic target of rapamycin kinase/Serine/threonine-protein kinase mTOR in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2842] [GtoPdb: 2109] [UniProtKB: P42345] | ||||||||
ChEMBL | Inhibition of mTOR (unknown origin) assessed as inhibition constant using GFP-4EBP1 as substrate by Lanthascreen based time resolved fluorescence based assay | B | 6.49 | pKi | 320 | nM | Ki | Eur J Med Chem (2020) 208: 112820-112820 [PMID:32966896] |
Signal transducer and activator of transcription 1-alpha/beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6101] [UniProtKB: P42224] | ||||||||
ChEMBL | Binding affinity to STAT1 (unknown origin) by surface plasmon resonance assay | B | 6.15 | pKd | 700 | nM | Kd | J Nat Prod (2014) 77: 543-549 [PMID:24417609] |
OATP2B1/Solute carrier organic anion transporter family member 2B1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1743124] [GtoPdb: 1224] [UniProtKB: O94956] | ||||||||
ChEMBL | Inhibition of human OATP2B1 expressed in Flp-In-CHO cells assessed as inhibition of OATP2B1 mediated DBF uptake using DBF as fluorescent substrate incubated for 2 mins by BCA assay | B | 4.1 | pIC50 | 79600 | nM | IC50 | RSC Med Chem (2023) 14: 890-898 [PMID:37252098] |
ChEMBL | Inhibition of human OATP2B1 expressed in Flp-In-CHO cells assessed as inhibition of OATP2B1 mediated DBF uptake using DBF as fluorescent substrate incubated for 2 mins by BCA assay | B | 4.1 | pIC50 | 79432.82 | nM | IC50 | RSC Med Chem (2023) 14: 890-898 [PMID:37252098] |
squalene monooxygenase/Squalene monooxygenase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4241] [GtoPdb: 2433] [UniProtKB: P52020] | ||||||||
ChEMBL | Compound was evaluated for its inhibitory activity against recombinant rat SE(squalene epoxidase) | B | 6.16 | pIC50 | 690 | nM | IC50 | Bioorg Med Chem Lett (2000) 10: 2525-2528 [PMID:11086721] |
ChEMBL | Inhibition of rat squalene epoxidase | B | 6.16 | pIC50 | 690 | nM | IC50 | J Nat Prod (2001) 64: 1010-1014 [PMID:11520216] |
Telomerase reverse transcriptase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2916] [UniProtKB: O14746] | ||||||||
ChEMBL | Inhibition of telomerase in human HeLa cells using 5'-AAT CCG TCG AGC AGA GTT-3' as substrate incubated for 15 mins prior to extension reaction by telomeric repeat amplification protocol | B | 5.93 | pIC50 | 1180 | nM | IC50 | J Med Chem (2012) 55: 3678-3686 [PMID:22413845] |
ChEMBL | Inhibition of telomerase in human HeLa cells using 5'-AAT CCG TCG AGC AGA GTT-3' as substrate incubated for 15 mins prior to extension reaction followed by compound washout by spin-telomeric repeat amplification protocol | B | 5.97 | pIC50 | 1080 | nM | IC50 | J Med Chem (2012) 55: 3678-3686 [PMID:22413845] |
ChEMBL | Inhibition of telomerase in human U937 cells | B | 6 | pIC50 | 1000 | nM | IC50 | J Med Chem (2012) 55: 3678-3686 [PMID:22413845] |
ChEMBL | Inhibition of telomerase (unknown origin) by TRAP assay | B | 6 | pIC50 | 1000 | nM | IC50 | Medchemcomm (2011) 2: 229-245 |
transthyretin/Transthyretin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3194] [GtoPdb: 2851] [UniProtKB: P02766] | ||||||||
ChEMBL | Binding affinity to recombinant human transthyretin expressed in Escherichia coli BL21 by STD-NMR spectroscopic method | B | 6.4 | pKd | 400 | nM | Kd | J Med Chem (2017) 60: 5749-5758 [PMID:28587455] |
ChEMBL | Binding affinity to wild type TTR (unknown origin) expressed in bacterial expression system by isothermal titration calorimetry | B | 6.4 | pKd | 400 | nM | Kd | J Med Chem (2020) 63: 14228-14242 [PMID:32914975] |
FYN proto-oncogene, Src family tyrosine kinase/Tyrosine-protein kinase FYN in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1841] [GtoPdb: 2026] [UniProtKB: P06241] | ||||||||
ChEMBL | Binding affinity to Fyn (unknown origin) assessed as dissociation constant | B | 6.44 | pKd | 367 | nM | Kd | Bioorg Med Chem (2023) 96: 117483-117483 [PMID:37951136] |
TAS2R5 in Human [GtoPdb: 662] [UniProtKB: Q9NYW4] | ||||||||
GtoPdb | - | - | 4.91 | pEC50 | 12300 | nM | EC50 | J Agric Food Chem (2018) 66: 8814-8823 [PMID:30056706] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]